Clinical trial
Modulating Effects of Lisinopril on Sildenafil Activity in PAH (MELISSA)
NCT01181284 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Modulating Effects of Lisinopril on Sildenafil Activity in PAH (MELISSA)
- Lead sponsor
- Mayo Clinic
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2008
- Completion date
- July 31, 2011
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.